Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 6/20 | 1.00 |
| ▸ | CES1 | P23141 | 5/20 | 1.00 |
| ▸ | MAOA | P21397 | 4/20 | 0.67 |
| ▸ | MAOB | P27338 | 4/20 | 0.67 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.56 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.55 |
| ▸ | PPOX | P50336 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | IDO1 | P14902 | 1/20 | 0.54 |
| ▸ | TDO2 | P48775 | 1/20 | 0.54 |
| ▸ | CAPN9 | O14815 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29506317 | 1.00 | TGM2 (1.00) | TGM2CES1MAOAMAOBCHEK1 | |
| SCHEMBL1462357 | 0.98 | TGM2 (0.96) | TGM2CES1MAOAMAOBCHEK1 | |
| Methane SCHEMBL27958656 | 0.98 | TGM2 (0.96) | TGM2CES1MAOAMAOBCHEK1 | |
| Nitrogen SCHEMBL29155961 | 0.96 | TGM2 (0.92) | TGM2CES1MAOAMAOBCHEK1 | |
| 5-Fluoroisatin SCHEMBL11132105 | 0.89 | CES1 (0.80) | TGM2CES1MAOAMAOBCHEK1 | |
| Acetamide SCHEMBL8705155 | 0.88 | TGM2 (0.77) | TGM2CES1MAOAMAOBCHEK1 | |
| SCHEMBL31139641 | 0.87 | CES1 (0.77) | TGM2CES1MAOAMAOBCHEK1 | |
| Phenol SCHEMBL674629 | 0.87 | CES1 (0.75) | TGM2CES1MAOAMAOBCHEK1 | |
| SCHEMBL4370977 | 0.85 | CES1 (0.73) | TGM2CES1MAOAMAOBCHEK1 | |
| N-Methylpiperidine SCHEMBL4627711 | 0.84 | CES1 (0.71) | TGM2CES1MAOAMAOBLRRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1034 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12594274-B2 | Method for preparing a crystalline form of rabeximod | Gulch Pharma AB (SE) | 2026-04-07 | — | — | US | claimed |
| CN-117586485-A | Sulfonated hydrocarbon polymer containing protecting group, synthesis method and application thereof in low-temperature proton exchange membrane fuel cell | 中国科学院山西煤炭化学研究所 | 2024-02-23 | — | — | CN | claimed |
| US-20230227455-A1 | METHOD FOR PREPARING A CRYSTALLINE FORM OF RABEXIMOD | CYXONE AB (SE) | 2023-07-20 | — | — | US | claimed |
| CN-111187233-B | Polysubstituted benzothiazole and derivative and synthesis method thereof | 湘潭大学 | 2023-05-30 | — | — | CN | claimed |
| EP-4165043-A1 | METHOD FOR PREPARING A CRYSTALLINE FORM OF RABEXIMOD | Cyxone AB (SE) | 2023-04-19 | — | — | EP | claimed |
| CN-115698010-A | Process for preparing a crystalline form of RABEXIMOD | 赛克松公司 | 2023-02-03 | — | — | CN | claimed |
| CN-110128320-B | Preparation method of 5-chloro-3-hydroxy-3-difluoroalkyl-indolin-2-one compound | 上海应用技术大学 | 2022-06-07 | — | — | CN | claimed |
| CN-113912609-A | Preparation method of natural alkaloid tryptanthrin and derivative thereof | 江苏大学 | 2022-01-11 | — | — | CN | claimed |
| WO-2021250197-A1 | METHOD FOR PREPARING A CRYSTALLINE FORM OF RABEXIMOD | CYXONE AB (SE) | 2021-12-16 | — | — | WO | claimed |
| CN-111574426-A | Diamine monomer containing isoindigo structure and black polyimide synthesized from diamine monomer | 湘潭大学 | 2020-08-25 | — | — | CN | claimed |
| US-20050262647-A1 | Agent for dyeing fibers containing keratin | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2005-12-01 | — | — | US | claimed |
| EP-1434557-B1 | AGENT FOR THE COLORATION OF KERATIN-CONTAINING FIBERS | HENKEL KGAA (DE) | 2005-11-09 | — | — | EP | claimed |
| US-20050144740-A1 | Agents used for dyeing keratinous fibers | HENKEL AG & CO. KGAA (DE) | 2005-07-07 | — | — | US | claimed |
| US-6743263-B1 | Method for coloring keratin fibers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2004-06-01 | — | — | US | claimed |
| US-6635090-B1 | Dyeing method using a specific cationic derivative and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative | L'OREAL, S.A. (FR) | 2003-10-21 | — | — | US | claimed |
| US-6458168-B1 | Hair dyeing method using an aliphatic cationic amine and compound chosen from an aldehyde, a ketone, a quinone, a di-imino-isoindoline, and a 3-aminoisoindolone derivative | L'OREAL S.A. (FR) | 2002-10-01 | — | — | US | claimed |
| US-6451067-B1 | HAIR DYE MIXTURE | L'OREAL S.A. (FR) | 2002-09-17 | — | — | US | claimed |
| US-6114540-A | COMBINATORIAL LIBRARIES | ARQULE, INC. (US) | 2000-09-05 | — | — | US | claimed |
| US-5993971-A | TRANSPARENT SUBSTRATE IS MADE OF A RESIN MATERIAL MAINLY CONSISTING OF A POLYCARBONATE RESIN THAT CONTAINS NO MORE THAN 4 WT % OF LOW MOLECULAR WEIGHT FRACTIONS IN ORDER TO AVOID A DOUBLE REFRACTION | SONY CORPORATION (JP) | 1999-11-30 | — | — | US | claimed |
| US-5021541-A | Better flowability and moblability | MITSUBISHI GAS CHEMICAL CO., LTD. (JP) | 1991-06-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227455-A1 | METHOD FOR PREPARING A CRYSTALLINE FORM OF RABEXIMOD | RAB2A, RAB9A, RAB10 | TGM2 3772/4885CES1 3224/4885MAOA 1401/4885 |
| US-12594274-B2 | Method for preparing a crystalline form of rabeximod | RAB10, RAB9A, RAB1A | TGM2 4109/4885CES1 2881/4885MAOA 630/4885 |
| US-20050144740-A1 | Agents used for dyeing keratinous fibers | KRT18, TUBB3, DSG1 | TGM2 1512/4885CES1 3830/4885MAOA 2422/4885 |
| US-20050262647-A1 | Agent for dyeing fibers containing keratin | KRT18, CKAP4, KRTCAP2 | TGM2 1412/4885CES1 2379/4885MAOA 322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.